Expert: Selective inhibitor of CYP11B2 (aldosterone synthase) that reduces aldosterone production while sparing cortisol synthesis.

Everyday: Blocks production of a hormone that raises blood pressure, for patients whose blood pressure is hard to control.

Targets: ["CYP11B2"]

Baxdrostat - Hypertension - FDA Approval Q2 2026

Aldosterone synthase inhibitor. First-in-class. PDUFA Q2'26.